<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>von Willebrand Assays | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of von Willebrand Assays  Definition: A panel of laboratory tests used to assess the quantity and function of von Willebrand factor (vWF), a protein essential for normal blood clotting...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="von Willebrand Assays | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of von Willebrand Assays  Definition: A panel of laboratory tests used to assess the quantity and function of von Willebrand factor (vWF), a protein essential for normal blood clotting...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="von Willebrand Assays | Hematology">
<meta name="twitter:description" content="Overview of von Willebrand Assays  Definition: A panel of laboratory tests used to assess the quantity and function of von Willebrand factor (vWF), a protein essential for normal blood clotting...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="active" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="von-willebrand-assays" class="section level1 unnumbered">
<h1>von Willebrand Assays<a class="anchor" aria-label="anchor" href="#von-willebrand-assays"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-von-willebrand-assays" class="section level2 unnumbered">
<h2>
<strong>Overview of von Willebrand Assays</strong><a class="anchor" aria-label="anchor" href="#overview-of-von-willebrand-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A panel of laboratory tests used to assess the quantity and function of von Willebrand factor (vWF), a protein essential for normal blood clotting</li>
<li>
<strong>Purpose:</strong>
<ul>
<li>Diagnosis of von Willebrand Disease (vWD): Confirms the diagnosis and helps classify the type of vWD</li>
<li>Differentiation of vWD from other Bleeding Disorders: Helps distinguish vWD from hemophilia and other platelet function disorders</li>
<li>Evaluation of Unexplained Bleeding: Used to investigate patients with a personal or family history of mucocutaneous bleeding</li>
<li>Monitoring Treatment: Used to monitor the response to treatment for vWD (e.g., desmopressin, vWF concentrates)</li>
</ul>
</li>
<li>
<strong>Key Assays:</strong>
<ul>
<li>vWF Antigen (vWF:Ag)</li>
<li>vWF Activity (vWF:RCo)</li>
<li>Factor VIII Activity (FVIII:C)</li>
<li>vWF Multimeric Analysis</li>
<li>Platelet Function Analyzer (PFA-100) - though not specific to vWF, it can assist in diagnosis</li>
</ul>
</li>
</ul>
</div>
<div id="components-of-von-willebrand-assays" class="section level2 unnumbered">
<h2>
<strong>Components of von Willebrand Assays</strong><a class="anchor" aria-label="anchor" href="#components-of-von-willebrand-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Specimen Collection:</strong>
<ul>
<li>Collection Tube: Sodium citrate (light blue top) tube with a 3.2% or 3.8% sodium citrate concentration</li>
<li>Blood-to-Anticoagulant Ratio: The correct ratio is critical for accurate coagulation testing:
<ul>
<li>9:1 ratio of blood to anticoagulant</li>
</ul>
</li>
<li>Processing:
<ul>
<li>Centrifuge the sodium citrate tube to obtain platelet-poor plasma (PPP)</li>
<li>PPP should have a platelet count &lt; 10 x 10^9/L</li>
<li>Test should be performed within 4 hours of collection or the plasma should be frozen if testing will be performed later. Specifics will vary from lab to lab</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Reagents:</strong>
<ul>
<li>vWF:Ag Reagent: Contains antibodies specific for vWF</li>
<li>vWF:RCo Reagent: Contains ristocetin, a substance that induces vWF-dependent platelet agglutination</li>
<li>Factor VIII Reagent: Contains purified factor VIII</li>
</ul>
</li>
</ul>
</div>
<div id="individual-assays" class="section level2 unnumbered">
<h2>
<strong>Individual Assays</strong><a class="anchor" aria-label="anchor" href="#individual-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>von Willebrand Factor Antigen (vWF:Ag):</strong></p>
<ul>
<li>
<em>Principle:</em> Measures the amount of vWF protein in the plasma, regardless of its function</li>
<li>
<em>Methods:</em>
<ul>
<li>Immunoturbidimetry: Measures the turbidity caused by the formation of antigen-antibody complexes</li>
<li>Nephelometry: Measures the light scattered by the antigen-antibody complexes</li>
<li>ELISA (Enzyme-Linked Immunosorbent Assay): Uses enzyme-labeled antibodies to detect vWF</li>
</ul>
</li>
<li>
<em>Procedure:</em>
<ol style="list-style-type: decimal">
<li>Add anti-vWF antibodies</li>
<li>Read for what test is used whether it is measuring the antibody or test light to determine the concentration with the reference range</li>
</ol>
</li>
<li>
<em>Reporting:</em>
<ul>
<li>Reported as a percentage of normal or in IU/dL</li>
<li>Reference Range: Varies depending on the laboratory and the assay used (e.g., 50-200%)</li>
</ul>
</li>
<li>
<em>Interpretation:</em>
<ul>
<li>Decreased vWF:Ag: Suggests a quantitative deficiency of vWF (seen in type 1 and type 3 vWD)</li>
<li>Normal vWF:Ag: Does not rule out vWD; may be seen in qualitative vWF defects (type 2 vWD)</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>von Willebrand Factor Activity (vWF:RCo):</strong></p>
<ul>
<li>
<em>Principle:</em> Measures the ability of vWF to bind to platelets in the presence of ristocetin, a cofactor that promotes vWF-dependent platelet agglutination</li>
<li>
<em>Method:</em>
<ul>
<li>Ristocetin-Induced Platelet Agglutination (RIPA):
<ul>
<li>Measures the rate of platelet agglutination after the addition of ristocetin and vWF-containing plasma</li>
<li>The degree of agglutination is proportional to the vWF activity</li>
</ul>
</li>
<li>Automated vWF Activity Assays:
<ul>
<li>Use modified latex particles coated with GPIbα (the vWF receptor on platelets)</li>
<li>Measure the binding of vWF to the latex particles in the presence of ristocetin</li>
<li>Automated latex agglutination test can also be called vWF:Glycoprotein 1b Binding Assay (vWF:GPIbM)</li>
</ul>
</li>
</ul>
</li>
<li>
<em>Procedure:</em>
<ol style="list-style-type: decimal">
<li>Test is ran through an analyzer</li>
<li>The agglutination is read</li>
</ol>
</li>
<li>
<em>Reporting:</em>
<ul>
<li>Reported as a percentage of normal or in IU/dL</li>
<li>Reference Range: Varies depending on the laboratory and the assay used (e.g., 50-200%)</li>
</ul>
</li>
<li>
<em>Interpretation:</em>
<ul>
<li>Decreased vWF:RCo: Suggests a functional defect in vWF (seen in most types of vWD)</li>
<li>Increased vWF:RCo: Seen in type 2B vWD (vWF has increased affinity for platelets)</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Factor VIII Activity (FVIII:C):</strong></p>
<ul>
<li>
<em>Principle:</em> Measures the activity of factor VIII, a coagulation protein that is bound to and stabilized by vWF</li>
<li>
<em>Methods:</em>
<ul>
<li>Chromogenic Assay: Measures the amount of activated Factor X (Factor Xa) produced in the presence of Factor VIII and other coagulation factors</li>
<li>Clotting Assay: Measures the ability of plasma to correct the aPTT of Factor VIII-deficient plasma</li>
</ul>
</li>
<li>
<em>Procedure:</em>
<ul>
<li>Follow <a href="factor-assays.html#factor-assays">Factor Assay</a> procedure</li>
</ul>
</li>
<li>
<em>Reporting:</em>
<ul>
<li>Reported as a percentage of normal or in IU/dL</li>
<li>Reference Range: Varies depending on the laboratory and the assay used (e.g., 50-150%)</li>
</ul>
</li>
<li>
<em>Interpretation:</em>
<ul>
<li>Decreased FVIII:C: Suggests vWD type 2N (decreased binding of vWF to FVIII) or hemophilia A (Factor VIII deficiency)</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>vWF Multimeric Analysis:</strong></p>
<ul>
<li>
<em>Principle:</em> Evaluates the distribution of vWF multimers, which are polymers of vWF subunits</li>
<li>
<em>Method:</em>
<ul>
<li>Gel Electrophoresis: vWF multimers are separated by electrophoresis on an agarose gel</li>
<li>Immunoblotting: The separated multimers are transferred to a membrane and detected with an antibody specific for vWF</li>
<li>Visualization: The multimers are visualized using a staining or detection method</li>
</ul>
</li>
<li>
<em>Interpretation:</em>
<ul>
<li>Normal Multimer Pattern: A full range of vWF multimers is present</li>
<li>Abnormal Multimer Pattern: Decreased high-molecular-weight multimers (HMW multimers) are seen in type 2A vWD</li>
</ul>
</li>
<li>
<em>Clinical Significance:</em> Helps differentiate type 2A vWD from other subtypes of vWD</li>
</ul>
</li>
</ul>
</div>
<div id="pfa-100-platelet-function-analyzer" class="section level2 unnumbered">
<h2>
<strong>PFA-100 (Platelet Function Analyzer)</strong><a class="anchor" aria-label="anchor" href="#pfa-100-platelet-function-analyzer"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Principle:</strong> Measures platelet function under high shear stress by aspirating blood through a small aperture coated with collagen and epinephrine or collagen and ADP</li>
<li>
<strong>Procedure:</strong>
<ul>
<li>A citrated whole blood sample is aspirated through a small aperture coated with collagen and either epinephrine or ADP</li>
<li>The time it takes for the aperture to become occluded by a platelet plug is measured (closure time)</li>
</ul>
</li>
<li>
<strong>Results:</strong>
<ul>
<li>Closure Time (CT):
<ul>
<li>Epinephrine Closure Time (Epi-CT): Measures platelet function in response to collagen and epinephrine</li>
<li>ADP Closure Time (ADP-CT): Measures platelet function in response to collagen and ADP</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Interpretation:</strong>
<ul>
<li>Prolonged Closure Time: Suggests platelet dysfunction
<ul>
<li>Prolonged Epi-CT and ADP-CT: May be seen in vWD, aspirin use, or other platelet function disorders</li>
</ul>
</li>
<li>Normal Closure Time: Does not rule out vWD or other platelet function disorders</li>
</ul>
</li>
<li>
<strong>Limitations:</strong>
<ul>
<li>Affected by Hematocrit: Must be performed on samples with a hematocrit within the specified range</li>
<li>Affected by Platelet count: Must be performed on samples with a platelet count within the specified range</li>
<li>Not Specific for vWD: Prolonged closure time can be seen in other platelet function disorders</li>
</ul>
</li>
</ul>
</div>
<div id="interpreting-von-willebrand-assay-results" class="section level2 unnumbered">
<h2>
<strong>Interpreting von Willebrand Assay Results</strong><a class="anchor" aria-label="anchor" href="#interpreting-von-willebrand-assay-results"><i class="fas fa-link"></i></a>
</h2>
<p>The following table summarizes the typical patterns of results seen in different types of vWD:</p>
<div class="inline-table"><table style="width:100%;" class="table table-sm">
<colgroup>
<col width="26%">
<col width="12%">
<col width="14%">
<col width="14%">
<col width="18%">
<col width="14%">
</colgroup>
<thead><tr class="header">
<th>vWD Type</th>
<th>vWF:Ag</th>
<th>vWF:RCo</th>
<th>FVIII:C</th>
<th>Multimers</th>
<th>PFA-100</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>Type 1</td>
<td>Low</td>
<td>Low</td>
<td>Low (may be)</td>
<td>Normal</td>
<td>Prolonged</td>
</tr>
<tr class="even">
<td>Type 2A</td>
<td>Normal or Low</td>
<td>Low</td>
<td>Normal</td>
<td>Decreased HMW multimers</td>
<td>Prolonged</td>
</tr>
<tr class="odd">
<td>Type 2B</td>
<td>Normal or Low</td>
<td>Increased</td>
<td>Normal</td>
<td>Normal</td>
<td>Prolonged</td>
</tr>
<tr class="even">
<td>Type 2M</td>
<td>Normal</td>
<td>Low</td>
<td>Normal</td>
<td>Normal</td>
<td>Prolonged</td>
</tr>
<tr class="odd">
<td>Type 2N</td>
<td>Normal</td>
<td>Normal</td>
<td>Low</td>
<td>Normal</td>
<td>Normal or Prolonged</td>
</tr>
<tr class="even">
<td>Type 3</td>
<td>Very Low</td>
<td>Very Low</td>
<td>Very Low</td>
<td>Absent</td>
<td>Prolonged</td>
</tr>
</tbody>
</table></div>
</div>
<div id="factors-affecting-von-willebrand-assay-results" class="section level2 unnumbered">
<h2>
<strong>Factors Affecting von Willebrand Assay Results</strong><a class="anchor" aria-label="anchor" href="#factors-affecting-von-willebrand-assay-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Pre-Analytical Variables:</strong></p>
<ul>
<li>Improper Collection Technique: Tissue thromboplastin contamination or hemolysis</li>
<li>Incorrect Blood-to-Anticoagulant Ratio: Underfilling or overfilling the collection tube</li>
<li>Clotted Sample: Invalidates the results</li>
<li>Delayed Testing: vWF and FVIII can degrade over time</li>
<li>Improper Storage: Incorrect storage temperatures can affect results</li>
</ul>
</li>
<li>
<p><strong>Analytical Variables:</strong></p>
<ul>
<li>Instrument Malfunction: Ensure proper calibration and maintenance of the coagulation analyzer</li>
<li>Reagent Problems: Use fresh, properly stored reagents and follow the manufacturer’s instructions</li>
<li>Interfering Substances: Lipemia or icterus can interfere with optical clot detection</li>
<li>Assay Sensitivity: Different assays have different sensitivities for detecting vWF abnormalities</li>
</ul>
</li>
<li>
<p><strong>Patient-Related Variables:</strong></p>
<ul>
<li>Blood Type: vWF levels are typically lower in individuals with blood type O</li>
<li>Age: vWF levels increase with age</li>
<li>Pregnancy: vWF levels increase during pregnancy</li>
<li>Estrogen Therapy: Increases vWF levels</li>
<li>Acute Phase Reactants: vWF is an acute phase reactant, so levels can increase during inflammation or infection</li>
</ul>
</li>
</ul>
</div>
<div id="troubleshooting-erroneous-results-8" class="section level2 unnumbered">
<h2>
<strong>Troubleshooting Erroneous Results</strong><a class="anchor" aria-label="anchor" href="#troubleshooting-erroneous-results-8"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the vWF assay results are unexpected or inconsistent with the patient’s clinical presentation:</p>
<ul>
<li>Check the sample for clots or hemolysis</li>
<li>Repeat the test on a fresh sample</li>
<li>Ensure that the correct blood-to-anticoagulant ratio was used</li>
<li>Verify the instrument and reagent quality control results</li>
<li>Consider repeating the vWF assays after a period of stability (to account for normal fluctuations in vWF levels)</li>
<li>Evaluate for potential interfering substances or medications</li>
<li>Consult with a pathologist or coagulation expert</li>
</ul>
</li>
</ul>
</div>
<div id="reflex-testing-4" class="section level2 unnumbered">
<h2>
<strong>Reflex Testing</strong><a class="anchor" aria-label="anchor" href="#reflex-testing-4"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the initial vWF assays are abnormal, further testing may be performed to:</p>
<ul>
<li>Characterize the type of vWD (e.g., multimer analysis, FVIII binding assay)</li>
<li>Rule out other causes of bleeding (e.g., platelet function disorders)</li>
<li>Perform genetic testing to identify specific vWF gene mutations</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-93" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-93"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>von Willebrand Factor (vWF):</strong> A protein that mediates platelet adhesion and carries factor VIII</li>
<li>
<strong>vWF Antigen (vWF:Ag):</strong> Measures the amount of vWF protein</li>
<li>
<strong>vWF Activity (vWF:RCo):</strong> Measures the ability of vWF to bind to platelets</li>
<li>
<strong>Factor VIII (FVIII:C):</strong> A coagulation protein that is carried by vWF</li>
<li>
<strong>Ristocetin:</strong> An antibiotic that induces vWF-dependent platelet agglutination</li>
<li>
<strong>Multimer Analysis:</strong> Evaluates the distribution of vWF multimers</li>
<li>
<strong>Platelet Function Analyzer (PFA):</strong> A test that measures platelet function under high shear stress</li>
<li>
<strong>Desmopressin (DDAVP):</strong> A synthetic analog of vasopressin that stimulates the release of vWF and factor VIII</li>
<li>
<strong>Type 1 vWD:</strong> Partial quantitative deficiency of vWF</li>
<li>
<strong>Type 2 vWD:</strong> Qualitative defects in vWF function</li>
<li>
<strong>Type 3 vWD:</strong> Severe quantitative deficiency of vWF</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="inhibitor-assays.html">Inhibitor Assays</a></div>
<div class="next"><a href="platelet-function.html">Platelet Function</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#von-willebrand-assays">von Willebrand Assays</a></li>
<li><a class="nav-link" href="#overview-of-von-willebrand-assays">Overview of von Willebrand Assays</a></li>
<li><a class="nav-link" href="#components-of-von-willebrand-assays">Components of von Willebrand Assays</a></li>
<li><a class="nav-link" href="#individual-assays">Individual Assays</a></li>
<li><a class="nav-link" href="#pfa-100-platelet-function-analyzer">PFA-100 (Platelet Function Analyzer)</a></li>
<li><a class="nav-link" href="#interpreting-von-willebrand-assay-results">Interpreting von Willebrand Assay Results</a></li>
<li><a class="nav-link" href="#factors-affecting-von-willebrand-assay-results">Factors Affecting von Willebrand Assay Results</a></li>
<li><a class="nav-link" href="#troubleshooting-erroneous-results-8">Troubleshooting Erroneous Results</a></li>
<li><a class="nav-link" href="#reflex-testing-4">Reflex Testing</a></li>
<li><a class="nav-link" href="#key-terms-93">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/book/05-21-hemostasis-laboratory-vwf-assays.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/book/05-21-hemostasis-laboratory-vwf-assays.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
